Credit Agricole
TGTX icon

Credit Agricole’s TG Therapeutics TGTX Stock Holding History

Credit Agricole’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,307,428
Closed -$10.5M – 519
2019
Q1 		$10.5M Hold
1,307,428
– – 0.57% 42
2018
Q4 		$5.36M Sell
1,307,428
-7,572
-0.6% -$37.6K 0.3% 77
2018
Q3 		$7.36M Buy
+1,315,000
New +$15M 0.35% 62

Other funds holding TGTX

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BM
Bridger Management New York $150M AUM 17.71% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Credit Agricole's TGTX Position: Q2 2019 in Review

Credit Agricole sold out of TG Therapeutics (TGTX) in Q2 2019, closing a stake of 1,307,428 shares — an estimated $10.5M sold.

Credit Agricole first reported a position in TGTX in Q3 2018 and held it in 3 quarters. The position peaked at $10.5M in Q1 2019. 116 funds tracked by Wall St. Rank hold TGTX as of Q2 2019.

  • Credit Agricole reported no remaining TG Therapeutics position as of Q2 2019 after selling out during the quarter.
  • Credit Agricole sold 1,307,428 TG Therapeutics shares in Q2 2019, an estimated $10.5M.
  • Credit Agricole first reported a position in TG Therapeutics in Q3 2018 and held it in 3 quarters.
  • Credit Agricole's TG Therapeutics position peaked at $10.5M in Q1 2019.
  • 116 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2019.

Based on Credit Agricole's 13F filing for Q2 2019, filed 14 Aug 2019.